CORE LABORATORIES INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $526.5M | $523.8M | $509.8M | $489.7M | $470.3M |
| Cost of Revenue | $417.6M | $420.5M | $400.0M | $393.7M | — |
| Gross Profit | $108.9M | $103.3M | $109.8M | $96.1M | — |
| Gross Margin | 20.7% | 19.7% | 21.5% | 19.6% | — |
| Operating Expenses | |||||
| Research & Development | — | — | — | — | — |
| SG&A Expense | $45.4M | $39.8M | $40.3M | $38.1M | — |
| Operating Income | $56.5M | $58.6M | $54.6M | $41.5M | $45.3M |
| Operating Margin | 10.7% | 11.2% | 10.7% | 8.5% | 9.6% |
| Interest Expense | $10.6M | $12.4M | $13.4M | $11.6M | $9.2M |
| Pretax Income | $45.9M | $46.2M | $41.2M | $30.0M | $36.1M |
| Income Tax Expense | $15.5M | $14.0M | $4.2M | $10.3M | $15.9M |
| Net Income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M |
| Net Margin | 5.6% | 6.0% | 7.2% | 4.0% | 4.2% |
| EPS (Basic) | $0.64 | $0.67 | $0.79 | $0.42 | $0.43 |
| EPS (Diluted) | $0.63 | $0.66 | $0.77 | $0.42 | $0.42 |
| Shares Outstanding (Basic) | 46.4M | 46.9M | 46.7M | 46.3M | 46.0M |
| Shares Outstanding (Diluted) | 47.0M | 47.7M | 47.5M | 46.8M | 46.7M |
| Dividends Per Share | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 |